Virtual reality could ease the sting of HIV injections

NCT ID NCT06834113

Recruiting now Symptom relief Sponsor: Centre Hospitalier Régional d'Orléans Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether changing the injection site (buttock vs. hip) or using a virtual reality headset can lower pain from HIV medications. 120 people with HIV will each try all four combinations and rate their pain. The goal is to find a simple way to make these injections more comfortable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cabotegravir and Rilpivirine (injectable antiretroviral drugs)
What this could lead to: If successful, this could show that a different injection site or a virtual reality headset makes HIV injections less painful, improving patient comfort.
What could go wrong: This is a small, early-stage study focused on pain, not on curing or controlling HIV. The results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV I INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV I INFECTION INJECTION PAIN

Contacts and locations

Locations

CH Chartres
RECRUITING

Le Coudray, 28630, France
CHD Vendée
RECRUITING

La Roche-sur-Yon, 85925, France
CHU Nantes
RECRUITING

Nantes, 44093, France
CHU Poitiers
RECRUITING

Poitiers, 90577, France
Center Hospitalier Universitaire d'Orléans
RECRUITING

Orléans, Loiret, 45067, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.